# Norikazu Masuda

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/norikazu-masuda/

## Facts

| Field | Value |
| --- | --- |
| Citations | 30,820 |
| Field | Breast Cancer Treatment Studies |
| h-index | 65 |
| i10-index | 240 |
| Last Known Institution | Kyoto University |
| OpenAlex ID | https://openalex.org/A5067189124 |
| ORCID iD | https://orcid.org/0000-0002-7302-0278 |
| Works | 698 |

## Researcher papers

- [Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy](https://scholariq.org/papers/adjuvant-capecitabine-for-breast-cancer-after-preoperative-chemotherapy/)
- [Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/neratinib-after-trastuzumab-based-adjuvant-therapy-in-her2-positive-breast/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)

## Researcher university

- [Kyoto University](https://scholariq.org/institutions/kyoto-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.